Sort by topic:

Episode 16: Encouraging Medication Adherence in Hepatitis C


 
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss issues related to medication adherence in the hepatitis C space.  
 
With the high cost, impressive cure rates, and relatively short treatment durations of new hepatitis C treatments, it is critical that patients adhere to their prescribed medication regimens. The panelists agreed that this is a typically noncompliant patient population, so Allen stressed the importance of frequent touch points, as with cancer patients. Rayburg said that every effort must be made to make sure patients understand that full compliance for 12 weeks will lead to a cure.
 
Karalis explained that many patients acquire hepatitis C through drug or alcohol abuse, and there is a wide array of possibilities for them to be noncompliant. Because of this, newer treatment options such as oral therapies or once-a-day options can be easier to manage. Adherence can be facilitated through excellent patient engagement and education, Ness added.  
 
*The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc. 
 
 


Episode #1

Episode 1: What is Specialty Pharmacy?
Episode 1: What is Specialty Pharmacy?

Episode #2

Episode 2: Understanding and Exploring the Practice of Specialty Pharmacy: How is quality measured?
Episode 2: Understanding and Exploring the Practice of Specialty Pharmacy: How is quality measured?

Episode #3

Episode 3: How Do Prior Authorization and Cost Impact Patient Care?
Episode 3: How Do Prior Authorization and Cost Impact Patient Care?

Episode #4

Episode 4 - Navigating Barriers to Therapy and Reimbursement
Episode 4 - Navigating Barriers to Therapy and Reimbursement

Episode #5

Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality
Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality

Episode #6

Episode 5: Is There Value to Specialty Pharmacy Accreditation?
Episode 5: Is There Value to Specialty Pharmacy Accreditation?

Episode #7

Episode 7: Data Aggregation in Specialty Pharmacy
Episode 7: Data Aggregation in Specialty Pharmacy

Episode #8

Episode 8: New Products and Limited Distribution Channels
Episode 8: New Products and Limited Distribution Channels

Episode #9

Episode 9: Role of Biosimilars in the Specialty Marketplace
Episode 9: Role of Biosimilars in the Specialty Marketplace

Episode #10

Episode 10: How Do We Know Specialty Pharmacies Are Providing Good Customer Service?
Episode 10: How Do We Know Specialty Pharmacies Are Providing Good Customer Service?

Episode #11

Episode 11: Management of High Cost Medications
Episode 11: Management of High Cost Medications

Episode #12

Episode 12: Value of Specialty Pharmacy in Oncology
Episode 12: Value of Specialty Pharmacy in Oncology

Episode #13

Episode 13: Challenges of Medication Adherence in the Oncology Population
Episode 13: Challenges of Medication Adherence in the Oncology Population

Episode #14

Episode 14: Strategies to Mitigate Side Effects and Management of Comorbidities
Episode 14: Strategies to Mitigate Side Effects and Management of Comorbidities

Episode #15

Episode 15: Are High Cost Hepatitis C Medications Worth the Price Tag?
Episode 15: Are High Cost Hepatitis C Medications Worth the Price Tag?

Episode #16

Episode 16: Encouraging Medication Adherence in Hepatitis C
Episode 16: Encouraging Medication Adherence in Hepatitis C

Episode #17

Segment 17: Managing Depression: Use of Counseling to Improve Outcomes
Segment 17: Managing Depression: Use of Counseling to Improve Outcomes

Episode #18

Segment 18: Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs
Segment 18: Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$